Assessing mNIS+7<sub>Ionis</sub> and international neurologists' proficiency in a familial amyloidotic polyneuropathy trialWilliam J. Litchy, Céline Labeyrie, Jessica Robinson‐Papp et al.|Muscle & Nerve|2017Cited by 56
Inotersen for the treatment of adults with polyneuropathy caused by hereditary transthyretin-mediated amyloidosisMorie A. Gertz, Laura Obici, Morton Scheinberg et al.|Expert Review of Clinical Pharmacology|2019Cited by 39
ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtableThomas H. Brannagan, Frederick L. Ruberg, Michaela Auer‐Grumbach et al.|Orphanet Journal of Rare Diseases|2021Cited by 16
Neurologic Involvement in Val-122 Ile Familial Amyloidosis (P1.026)Sami Khella, Mathew S. Maurer, Brian Drachman et al.|Neurology|2014Cited by 1